- Home
- NBP vs PCYO Comparison
NBP vs PCYO Comparison
Compare NBP & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBP | PCYO |
|---|---|---|
| Founded | 2014 | 1976 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.2M | 242.8M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NBP | PCYO |
|---|---|---|
| Price | $2.41 | $11.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 53.8K |
| Earning Date | 04-07-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.50 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $1,227,787.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $50.17 |
| Revenue Growth | N/A | ★ 171.54 |
| 52 Week Low | $2.10 | $9.65 |
| 52 Week High | $5.19 | $12.16 |
Technical Indicators
Market Signals| Indicator | NBP | PCYO |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 54.67 |
| Support Level | $2.27 | $10.71 |
| Resistance Level | $2.78 | $11.63 |
| Average True Range (ATR) | 0.14 | 0.34 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 21.05 | 53.13 |
Price Performance
Historical ComparisonAbout NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.